CTOs on the Move

La Jolla Pharmaceutical Company

www.ljpc.com

 
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has four product candidates in development. LJPC-501 is La Jolla’s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome. GCS-100 is La Jolla’s first-in-class galectin-3 inhibitor for the potential treatment of chronic kidney disease. LJPC-1010, La Jolla’s second-generation galectin-3 inhibitor, is a more potent and purified derivative of GCS-100 that can be delivered orally for the potential treatment of nonalcoholic steatohepatitis and other ...
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million
  • www.ljpc.com
  • 4370 La Jolla Village Dr Ste 400
    San Diego, CA USA 92122
  • Phone: 858.207.4264

Executives

Name Title Contact Details

Similar Companies

Digestive Care Inc

Digestive Care Inc is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Comparative Biosciences Inc

Comparative Biosciences Inc is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fagron US

Fagron NV is a publicly traded multinational group of companies governed by Belgian law.

Wellinks

Wellinks is a virtual COPD management solution empowering members to live fully, and breathe freely.

Irix Pharmaceuticals

Irix Pharmaceuticals is a Florence, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.